This study was done to find the effectiveness of neuromuscular electrical stimulation (NMES) over anterior neck muscles. Sixteen patients, age range 50 to 80 years with pharyngeal dysphagia of neurological origin were included for study. A similar age-matched control group of 16 patients was taken from medical records. Detailed history, clinical assessment, investigations that are a flexible endoscopic evaluation of swallowing (FEES) and videofluoroscopic study of swallowing (VFS) was done. Subjective response (percentage of total diet taken orally) and penetration-aspiration scale (PAS) score at the beginning of treatment were noted. NMES was given to the study group along with swallow therapy. The suprahyoid muscles were stimulated regularly for 2 weeks. The reassessment was done after 2 weeks. The control group received only swallow therapy but no NMES. The results of the control group were also noted. Changes in the percentage of the total quantity of diet taken orally were asked. Upgradation in PAS score was assessed using FEES and VFS. The satisfactory improvement was found within 2 weeks in the study group. This took about 2 months in the control group. Hence, NMES was found to be an effective tool for dysphagia management.
INTRODUCTION
Neuromuscular electrical stimulation (NMES) is transcutaneous galvanic stimulation in small amounts of the motor nerve endings that innervate muscles beneath the skin. It stimulates the central nervous system (CNS) stimulation and causes involuntary muscle contraction 1 in patients with CNS abnormalities but intact peripheral nerve function. 2 This effect was first established by Luigi Galvani in 1761. It keeps the muscle function intact and recruits more muscle fibers, thus, helps to strengthen muscles and prevents atrophy. 3, 4 Hence it causes quick re-education of CNS by stimulating the sensory pathways. NMES has been clinically used for the treatment of facial palsy. 5 It is also used in vocal fold palsy. Other fields of use are in sports medicine, 6 after knee arthroplasty, in spastic diplegic cerebral palsy cases. NMES received FDA approval in 2002 for use in dysphagia in the laryngeal neck region. It was marketed as VitalStim (Chattanooga Group Hixon TN). The clinical uses in dysphagia mainly neurological (CVA, degenerative disease, geriatric patients), post-radiotherapy fibrosis, and post head and neck surgery with reconstruction. NMES is used in dysphagia as it is a non-invasive method and decreases recovery time. This stimulates the hyolaryngeal muscles and causes faster improvement in Laryngeal elevation, which is needed for airway protection. This prevents aspiration increasing swallow safety. It also helps better functioning of the pharyngeal pump and combined with traditional swallow exercise it speeds up recovery time. [7] [8] [9] Contraindications are an active neoplasm, the presence of implantable electronic devices, history of seizures, the presence of infection, secretions, bleeding areas, placement of electrodes over carotid sinus, during radiation and chemotherapy, pregnancy, patients on ventilators and with metal tracheotomy tubes. 10 There are some existing studies in the Indian scenario. 
ORIGINAL ARTICLE
by Mehendiratta et al. in a recent study in 2017. 13 The aim of our study is to find the effectiveness of NMES on anterior neck muscle strengthening in neurology patients with pharyngeal dysphagia. We used the Penetrationaspiration Scale score and percentage of total diet taken orally as our evaluation parameters.
MATERIALS AND METHODS
Total 16 patients of isolated pharyngeal dysphagia of neurological origin were selected from cases of Neuro Rehab Unit of a tertiary care hospital. Age of the patients ranged 50 to 82 years (average age 62.4 years). The study was conducted over a period of one year (January to December 2017). The pre-stimulation assessment was done through history, clinical examination. Flexible endoscopic evaluation of swallowing (FEES) was performed in all patients. Videofluoroscopic assessment of swallowing (VFS) was also carried out unless there was a contraindication. The penetration-aspiration scale (PAS) score was determined (Table1). PAS score was used for objective evaluation.
The penetration-aspiration scale in Table 1 is an 8 point scoring system. Score 1 means no penetration or aspiration, 2 to 5 represents penetration of different grades and 6 to 8, aspiration in increasing severity. The patient and relatives were asked about the amount of food the patient used to take before the onset of dysphagia. Then they were asked to quantify how much food the patient was able to take per month after the onset of a swallowing disorder. This percentage of total diet taken orally was taken as a subjective parameter. The treatment protocol was decided in a multidisciplinary setting involving Otolaryngologist, Speech Language Pathologist (SLP) and Neurophysician. The dual channel neuromuscular electrical stimulator (Model: VitalStim Plus. Make: Chattanooga) was used. The electrodes were placed on both sides over the suprahyoid muscles (Montage Placement 2a). NMES was given for 2 weeks at 2 to 3 mA, 60 minutes daily. The duration and intensity of current were readjusted during therapy. This was done accordingly as the muscles regained strength and retrained. The patients' subjective response to the stimulation was also taken into consideration. During the administration of NMES swallow therapy was also given. Each patient was individualized and made to perform different exercises such as chin tuck, head turn. After 2 weeks of treatment, a reassessment was done using the same method. PAS score was assessed. Initially, the patient oral intake was reduced to 10-20% of total diet, in many swallows was not safe and all CVA patients were on nasogastric tube feed. Post-therapy improvement in the amount of dietary intake was noted (subjective response). A retrospective case note study of 16 age-matched patients of neurological pharyngeal dysphagia was done. These patients were also assessed in the same way. History, clinical examination, noting the amount of dietary intake; FEES, VFS, and determination of PAS score were carried out. Similar swallow therapy was given but no NMES was administered. This was taken as our control group and their clinical improvement at 2 weeks was noted.
RESULTS
The spectrum of diagnosis of sixteen patients in the study group is depicted in Table 2 and those of the control group in Table 3 . Table 2 shows the pre and post-therapy data of the study group. There was a total of 16 patients with neurological pharyngeal dysphagia (cerebrovascular changes in PAS score in both the groups assessed. Graph 1 is a bar diagram showing the improvement in PAS score after NMES. Of total 10 CVA patients PAS improved to 2 in 8, and 3 in 2 patients. Of the MND cases, 1 showed score 2 and the other 3 after treatment. It was the same for PD cases. Patients of LMS were 2 in number, and both after 2 weeks of NMES, showed an improvement in PAS score from 6 to 2. The control group PAS score improvement post-therapy without NMES, as a bar diagram presentation in Graph 2. It shows, of 10 CVA cases, 4 had PAS score 4 and 6 had score 3. The 2 MND cases, one had score 4 and the other 3. Both PD patients had a post-therapy score of 3 after 2 weeks as also the 2 LMS cases. Table  1 , as already stated earlier shows the PAS score (Woods et al. 1996) we used for objective evaluation of patients using FEES and VFS before and after management. The change in the percentage of total diet that could be taken orally without aspiration was the standard of subjective improvement of patients. Figures 1 and 2 that represent the post-therapy percentage of total diet that could be taken orally without aspiration in the study and control groups respectively. Figure 1 is a pie chart showing posttherapy oral dietary intake in the study group. Hereafter 2 weeks of NMES, of the total 16 cases, 12 could take 50 to 60 % of their diet safely, orally and 4 could take 40 to 50%. Figure 1 is the pie chart representation of the control group. This chart highlights that after 2 weeks of exercise only, without any NMES, from the initial amount of 10 to 20%, in 10 patients the amount of diet they could take orally was 40 to 50 % of the total amount. In the remaining 6 cases, it was 30 to 40 % of the total amount.
DISCUSSION
Dysphagia is described as swallowing disorder usually resulting from a neurological or physical impairment of oral, pharyngeal or oesophageal mechanisms. The accident, motor neuron disease, Parkinson's disease, lateral medullary syndrome). Initially, their PAS score was between 6 and 5. They could take only 10 to 20 % of their total diet orally with difficulty. After 2 weeks of neuromuscular electrical stimulation added to exercises, their PAS score could be upgraded to 3 or 2, and, they could take 50 to 60 5 of their total diet orally and safely. Table 3 represents the spectrum of 16 patients of the retrospective control group. Here again, their pre-therapy PAS score was between 6 and 5, and they could hardly take 10 to 20% of their total dietary amount orally. They were given only exercises. No NMES was given to these patients. After 2 weeks reassessment showed PAS score between 4 and 3, and their oral dietary intake increased to 30 to 40 % of the total amount they used to take. Graphs 1 and 2 are the graphical representation of pre and post therapy 17 They concluded that their result was significant, where the study was small. Hence they felt the need for more research on this aspect.
In the study we did, there were 16 patients where we combined traditional therapy with NMES. Our retrospective control group also consisted of 16 patients. This was also a small study. But there was a significant improvement in using NMES, in our study too.
CONCLUSION
Hence NMES is an effective tool in the management of pharyngeal dysphagia of neurological origin. Our study also confirms that adding NMES results in superior and faster outcome compared to traditional swallow therapy in neurological pharyngeal dysphagia.
CLINICAL RELEVANCE
Neurological pharyngeal dysphagia can be treated effectively with NMES to achieve superior and faster recovery. NMES should be added to the armamentarium of any swallowing clinic, dealing with neurological pharyngeal dysphagia.
